A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
<h4>Purpose</h4>The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs).<h4>Experimental design</h4>Protein lysates from fresh-frozen 434 advanc...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2013-01-01
|
| Col·lecció: | PLoS ONE |
| Accés en línia: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054644&type=printable |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
